Wellington Management Group LLP 13D and 13G filings for Blueprint Medicines Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | Blueprint Medicines Corporation BPMC | Wellington Management Group LLP | 3,073,306 4.800% | -1,203,027 (-28.13%) | Filing |
| 2024-02-08 10:11 am Sale | 2023-12-29 | 13G | Blueprint Medicines Corporation BPMC | Wellington Management Group LLP | 4,276,333 7.030% | -727,095 (-14.53%) | Filing |
| 2023-02-06 2:49 pm Purchase | 2022-12-30 | 13G | Blueprint Medicines Corporation BPMC | Wellington Management Group LLP | 5,003,428 8.360% | 1,526,103 (+43.89%) | Filing |
| 2022-02-04 09:15 am Purchase | 2021-12-31 | 13G | Blueprint Medicines Corporation BPMC | Wellington Management Group LLP | 3,477,325 5.910% | 2,440,695 (+235.45%) | Filing |
| 2021-02-03 2:14 pm Sale | 2020-12-31 | 13G | Blueprint Medicines Corporation BPMC | Wellington Management Group LLP | 1,036,630 1.860% | -1,499,997 (-59.13%) | Filing |